MorphoSys AG (LTS:0NDV)
€ 66.8 0 (0%) Market Cap: 2.53 Bil Enterprise Value: 2.49 Bil PE Ratio: 0 PB Ratio: 51.57 GF Score: 45/100

MorphoSys AG at Citi BioPharma Conference (Virtual) Transcript

Sep 09, 2021 / 12:50PM GMT
Release Date Price: €45.49 (-0.76%)
Vineet R Agrawal
Citigroup Inc., Research Division - Research Analyst

Great. Good morning to those who are joining from the U.S., good afternoon to those in Europe, and good evening to everyone joining from Asia. It's the second day of our biopharma conference. Thanks for joining us. My name is Vineet Agrawal, and I'm delighted to have MorphoSys CEO, Jean-Paul Kress; and CFO, Sung Lee, with us for a fireside chat.

Now before that, I just wanted to remind investors on the call, if you have any questions, please feel free to use the chat function on your screens or e-mail me, and I'll make sure to ask the management. So Jean-Paul and Sung, welcome, and great to see you both.

Jean;Paul Kress
MorphoSys AG - Chairman of Management Board, MD & CEO

Thanks. Thanks very much. Thanks for having us.

Vineet R Agrawal;Jean<
Citigroup Inc., Research Division - Research Analyst

So maybe, Jean-Paul, you can start with some opening remarks and then we can head straight into Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot